Integrated lead optimisation to advance APEIRON’s Cbl-b inhibitor development programme APN431... Nov 11
Case study from promising first COVID-19 patient treatment with APN01 supports APEIRON's ongoing pivotal Phase II clinical trial ... Sep 25
-Advertisements-